Bapotulimab
Bapotulimab (BAY-1905254) is a fully human IgG2 antibody targeting immunoglobulin-like domain containing receptor 2 (ILDR2) . Bapotulimab has antitumor and immunosuppressive effects[1].
Product Specifications
CAS Number
[2359413-58-2]
Product Name Alternative
BAY-1905254
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bapotulimab.html
Purity
95.00
Solubility
10 mM in DMSO
Smiles
[Bapotulimab]
Molecular Weight
(144.98 kDa)
References & Citations
[1]Julia Huetter, et al. Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2) . Cancer Immunol Res. 2020 Jul;8 (7) :895-911.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
446133-01 10 mg
Des- (4-dimethylamino-2-en-1-oxo) butylamino 6- (5-Amino-pyrrolidin-2-on-1-yl) Afatinib
Ask
View Details 
446133-02 25 mg
Des- (4-dimethylamino-2-en-1-oxo) butylamino 6- (5-Amino-pyrrolidin-2-on-1-yl) Afatinib
Ask
View Details